Larvol Delta - Cardiff-Oncology-to-Present-Updated-Phase-2-Data-of-Onvansertib-in-FirstLine-RASMutated-mCRC-in-a-Rapid-Oral-Session-at-ASCO-2026

onvansertib (PCM-075) - Cardiff Oncology

https://finance.yahoo.com/sectors/healthcare/articles/cardiff-oncology-present-updated-phase-140000072.html

Apr 21, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next